Regenerative Medicine For Cartilage Market Global Outlook 2021 to 2027 - B. Braun Melsungen AG; Zimmer Biomet Holdings Inc.; Vericel Corporation; Stryker Corporation

Global Regenerative Medicine For Cartilage Market Size and Forecast to 2021 – 2030 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide a detailed description of the value chain and its distributor analysis. This Market study provides comprehend Regenerative Medicine For Cartilage data that enhances the understanding, scope, and application of this report.

The study includes market share analysis and profiles of players such as B. Braun Melsungen AG; Zimmer Biomet Holdings Inc.; Vericel Corporation; Stryker Corporation; Smith & Nephew plc; Arthrex Inc.; CONMED Corporation; Collagen Solutions PLC; BioTissue Technologies; CellGenix; Osiris Therapeutics Inc.; DePuy Synthes.

Click here to get a free sample copy of the latest research on Regenerative Medicine For Cartilage market (Flat 25% Off):

https://www.marketinsightsreports.com/reports/05182898449/regenerative-medicine-for-cartilage-global-market-report-2021-covid-19-growth-and-change-including-1-by-treatment-modality-cell-based-non-cell-based-2-by-treatment-type-palliative-intrinsic-repair-stimulus-others-3-by-site-knee-cartilage-repair-ribs-others-4-by-application-hyaline-cartilage-repair-and-regeneration-elastic-cartilage-repair-and-regeneration-fibrous-cartilage-repair-and-regeneration-5-by-end-use-ambulatory-surgical-centers-hospitals-clinics-surgical-centers-others-covering-b-braun-melsungen-ag-zimmer-biomet-holdings-inc-vericel-corporation-stryker-corporation-smith-nephew-plc/inquiry?Mode=A28

The global regenerative medicine for cartilage market is expected to grow from $4.47 billion in 2020 to $4.83 billion in 2021 at a compound annual growth rate (CAGR) of 8.10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.56 billion in 2025 at a CAGR of 7.94%.

Market Overview:

The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies, and in turn, result in a lower preference for these procedures.

In April 2019, Smith & Nephew plc, a UK-based multinational medical equipment manufacturing company, acquired Osiris Therapeutics, Inc. for approximately $660 million. The acquisition is expected to stimulate growth from Smith & Nephew’s advanced wound management franchise. Osiris Therapeutics, Inc. is a US-based company that researches and develops therapeutic products for the regeneration of human connective tissues.

The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation in 2019, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the market for regenerative medicine for cartilage.

Market Scope:

1) By Treatment Modality: Cell-Based; Non-Cell-Based

2) By Treatment Type: Palliative; Intrinsic Repair Stimulus; Others

3) By Site: Knee Cartilage Repair; Ribs; Others

4) By Application: Hyaline Cartilage Repair and Regeneration; Elastic Cartilage Repair and Regeneration; Fibrous Cartilage Repair and Regeneration

5) By End-Use: Ambulatory Surgical Centers; Hospitals & Clinics; Surgical Centers; Others

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/05182898449/regenerative-medicine-for-cartilage-global-market-report-2021-covid-19-growth-and-change-including-1-by-treatment-modality-cell-based-non-cell-based-2-by-treatment-type-palliative-intrinsic-repair-stimulus-others-3-by-site-knee-cartilage-repair-ribs-others-4-by-application-hyaline-cartilage-repair-and-regeneration-elastic-cartilage-repair-and-regeneration-fibrous-cartilage-repair-and-regeneration-5-by-end-use-ambulatory-surgical-centers-hospitals-clinics-surgical-centers-others-covering-b-braun-melsungen-ag-zimmer-biomet-holdings-inc-vericel-corporation-stryker-corporation-smith-nephew-plc?Mode=A28

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the Organic Soft Drinks market.

Region Coverage: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Countries Coverage: USA, France, Germany, UK, China, Australia, India, Indonesia, Japan, South Korea, Russia, Brazil

The study objectives of this report are:

To study and analyze the global Regenerative Medicine For Cartilage size (value and volume) by the company, key regions/countries, products and application, history data from 2020 to 2025, and forecast to 2030.
To understand the structure of Regenerative Medicine For Cartilage by identifying its various sub-segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Regenerative Medicine For Cartilage manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
To analyze the Regenerative Medicine For Cartilage with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Regenerative Medicine For Cartilage submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Purchase full Report@:

https://www.marketinsightsreports.com/report/purchase/05182898449?mode=su?Mode=A28

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.